MANILA, Jan. 14 (Xinhua) -- The Philippines' Food and Drug Administration (FDA) has authorized the emergency use of Pfizer Inc and BioNTech SE's COVID-19 vaccine, FDA head Enrique Domingo said on Thursday.
"Based on the totality of evidence available to date, including data from adequate and well-known controlled trials, it is reasonable to believe that the Pfizer-BioNTech COVID-19 vaccine may be effective to prevent, diagnose, or treat COVID-19," Domingo said at an online briefing.
He added that "the known and potential benefits of the Pfizer vaccine when used to diagnose, prevent, treat COVID-19, outweigh the known and potential risks of said vaccine as of date."
Domingo said the emergency use authorization (EUA) for the Pfizer-BioNTech vaccine "is effective immediately."
Pfizer applied for EUA on Dec. 23 last year.
Meanwhile, Domingo said China's Sinovac Biotech applied for EUA on Wednesday. "Pre-assessment" of the application is ongoing, he added.
Aside from Sinovac, the FDA has yet to approve the COVID-19 vaccines and EUA applications filed by AstraZeneca and Russia's Gamaleya.
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
"She power" plays indispensable role in poverty alleviation
Top 10 world news events of People's Daily in 2020
Top 10 China news events of People's Daily in 2020
Top 10 media buzzwords of 2020
Year-ender:10 major tourism stories of 2020
No interference in Venezuelan issues
Biz prepares for trade spat
Broadcasting Continent
Australia wins Chinese CEOs as US loses
